Definium Therapeutics DFTX
NASDAQ DFTX
$36.04 +0.95 (+2.71%)
As of: Oct 21, 2026 · 2:07 PM EDT

Definium Therapeutics (DFTX) Net Margin (2022 - 2023)

Updated

Analysis

Definium Therapeutics (DFTX) Net Margin (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,133.90 Bn 1,102.48 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 616.46 Bn 534.99 Bn 17.26 Bn 21.86%
3 AbbVie 501.26 Bn 474.37 Bn 12.70 Bn 21.27%
4 Merck 367.00 Bn 321.38 Bn 12.21 Bn -8.04%
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 16.30%
7 Amgen 235.82 Bn 191.22 Bn 7.24 Bn 23.62%
8 Gilead Sciences 190.63 Bn 164.82 Bn 6.22 Bn -134.51%
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn -1.65%
10 Definium Therapeutics 3.99 Bn 1.91 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -2,636.91%
Sep 30, 2023 -1,541.10%
Jun 30, 2023 -2,221.97%
Mar 31, 2023 -1,932.63%
Dec 31, 2022 -466.06%
Sep 30, 2022 -4,579.17%
Jun 30, 2022 -20,679.27%
API Access

Definium Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=DFTX&period=max&api_key=YOUR_API_KEY